Publication Name	World Journal of Stem Cells
Manuscript ID	47725
Country	Italy

Received	2019-03-22 01:51
Peer-Review Started	2019-03-22 08:57
To Make the First Decision	2019-08-06 02:55
Return for Revision	2019-08-06 08:17
Revised	2019-08-12 14:49
Second Decision	2019-08-28 00:35
Accepted by Journal Editor-in-Chief	2019-08-30 19:21
Accepted by Company Editor-in-Chief	2019-09-11 22:48
Articles in Press	2019-09-11 22:48
Publication Fee Transferred
Edit the Manuscript by Language Editor	2019-09-18 00:43
Typeset the Manuscript	2019-10-14 10:27
Publish the Manuscript Online	2019-11-05 08:52

ISSN	1948-0210 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Cell Biology
Manuscript Type	Review
Article Title	CRISPR/Cas system: An emerging technology in stem cell research
Manuscript Source	Invited Manuscript
All Author List	Maria Teresa Valenti, Michela Serena, Luca Dalle Carbonare and Donato Zipeto
Funding Agency and Grant Number
Corresponding Author	Maria Teresa Valenti, BSc, PhD, Chief Technician, Research Fellow, Department of Medicine, University of Verona, Ple Scuro 10, Verona 37100, Italy. mariateresa.valenti@univr.it
Key Words	Gene editing; CRISPR/Cas9; Stem cells; Degenerative diseases; ;
Core Tip	The possibility of translating new molecular knowledge systems to clinical research is particularly appealing for counteracting degenerative diseases as well as infective pathologies and cancer. A novel gene-editing technique, CRISPR/Cas9, has recently emerged for inducing targeted genetic modifications. Therefore, in this review, we describe recent applications of CRISPR/Cas9 to Stem Cells for counteracting degenerative diseases.
Publish Date	2019-11-05 08:52
Citation	Valenti MT, Serena M, Carbonare LD, Zipeto D. CRISPR/Cas system: An emerging technology in stem cell research. World J Stem Cells 2019; 11(11):937-956
URL	https://www.wjgnet.com/1948-0210/full/v11/i11/937.htm
DOI	https://dx.doi.org/10.4252/wjsc.v11.i11.937

Full Article (PDF)	WJSC-11-937.pdf
Full Article (Word)	WJSC-11-937.docx
Manuscript File	FP7012_ce5_CE1 MS-edit2-2.docx
Answering Reviewers	47725-Answering reviewers.pdf
Audio Core Tip	47725-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	47725-Conflict-of-interest statement.pdf
Copyright License Agreement	47725-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	47725-Language certificate.pdf
Peer-review Report	47725-Peer-review(s).pdf
Journal Editor-in-Chief Review Report	47725-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	47725-Scientific misconduct check.pdf
Scientific Editor Work List	47725-Scientific editor work list.pdf